Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Targeted Cancer Therapies & Biofluid Biopsies

Aditi Chatterjee's Biography



Aditi Chatterjee, Faculty Scientist, Institute of Bioinformatics

Dr Aditi Chatterjee obtained her Ph.D. degree in Biochemistry from the University of Calcutta, India. After completing her graduate studies, she joined the Johns Hopkins University School of Medicine in Baltimore, USA, as a Postdoctoral fellow in Radiation Oncology. Subsequently, she completed a Senior Postdoctoral Fellowship in the Division of Head and Neck Cancer Research in the Department of Otolaryngology at Johns Hopkins University School of Medicine. She received the 'Young Clinical Scientist Award' from Flight Attendant Medical Research Institute, Florida, which enabled her transition to an independent Faculty position as an Instructor at Johns Hopkins University.
Her research interests includes molecular genetics and proteomic alterations that drives the progression of different types of cancer associated with tobacco. This includes head and neck squamous cell carcinoma (HNSCC), esophageal and lung cancer. She and her group are specifically interested in the molecular epidemiology of tobacco-induced cancers for the identification of novel therapeutic targets for cancer and development of early detection markers using body fluids. Her group have identified molecular signatures based on the type of tobacco (smoking or smokeless) used in inducing various tumors. This approach may one day be the standard for stratifying patients with cancer and will allow more personalized therapy in patients with minimal residual disease. Irrespective of the area of my research, the aim is always to bridge basic research into clinical application.

Aditi Chatterjee Image

Delineating Tobacco induced Cellular Transformations in Oral Cancer

Friday, 26 May 2017 at 12:15

Add to Calendar ▼2017-05-26 12:15:002017-05-26 13:15:00Europe/LondonDelineating Tobacco induced Cellular Transformations in Oral CancerTargeted Cancer Therapies and Biofluid Biopsies in BengaluruBengaluruSELECTBIOenquiries@selectbiosciences.com

This talk will discuss how both chewing and smoking tobacco causes oral cancer but the molecular alterations brought about by each insult is different. Amongst the proteins which was overexpressed in both smoked and smokeless form of tobacco was Stearoyl-CoA desaturase. The presenter will highlight that SCD can act as a potential therapeutic target in head and neck squamous cell carcinoma, especially in patients who are users of tobacco.


Add to Calendar ▼2017-05-25 00:00:002017-05-26 00:00:00Europe/LondonTargeted Cancer Therapies and Biofluid BiopsiesTargeted Cancer Therapies and Biofluid Biopsies in BengaluruBengaluruSELECTBIOenquiries@selectbiosciences.com